null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

The Regulation of Cannabis in Europe (Of Highs and Laws)

List Price: $73.99
SKU:
9781032822037
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Robin Hofmann
    Format:
    Hardcover
    Pages:
    120
    Publisher:
    Taylor & Francis (March 19, 2025)
    Imprint:
    Routledge
    Language:
    English
    Audience:
    College/higher education
    ISBN-13:
    9781032822037
    Dimensions:
    5.4375" x 8.5"
    File:
    TAYLORFRANCIS-TayFran_260107055151746-20260107.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $73.99
    Country of Origin:
    United States
    Pub Discount:
    30
    As low as:
    $70.29
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Weight:
    10oz
  • Overview

    This book delves into the evolving landscape of cannabis regulation across Europe and the world. Starting with Germany’s push for full legalization, the work highlights hurdles faced by policymakers. It offers a detailed analysis of international and European frameworks restricting drug policy reform and discusses loopholes to avoid them.